CervoMed Inc (CRVO)
18.69
-0.24
(-1.27%)
USD |
NASDAQ |
May 24, 16:00
18.58
-0.11
(-0.59%)
After-Hours: 20:00
CervoMed Cash from Operations (Quarterly): -1.424M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.424M |
| December 31, 2023 | -2.538M |
| September 30, 2023 | 2.703M |
| June 30, 2023 | -6.132M |
| March 31, 2023 | -1.482M |
| December 31, 2022 | -0.6925M |
| September 30, 2022 | 6.857M |
| June 30, 2022 | -4.007M |
| March 31, 2022 | -4.730M |
| December 31, 2021 | -3.026M |
| September 30, 2021 | -2.972M |
| June 30, 2021 | -3.327M |
| March 31, 2021 | -5.176M |
| December 31, 2020 | -3.395M |
| September 30, 2020 | -3.51M |
| June 30, 2020 | -3.144M |
| March 31, 2020 | -3.504M |
| December 31, 2019 | -2.438M |
| September 30, 2019 | -2.153M |
| June 30, 2019 | -2.610M |
| March 31, 2019 | -2.658M |
| December 31, 2018 | -3.027M |
| September 30, 2018 | -1.916M |
| June 30, 2018 | -2.54M |
| March 31, 2018 | -3.289M |
| Date | Value |
|---|---|
| December 31, 2017 | -2.282M |
| September 30, 2017 | -3.888M |
| June 30, 2017 | -2.746M |
| March 31, 2017 | -3.416M |
| December 31, 2016 | -1.414M |
| September 30, 2016 | -1.865M |
| June 30, 2016 | -2.859M |
| March 31, 2016 | -4.630M |
| December 31, 2015 | -2.266M |
| September 30, 2015 | -0.9817M |
| June 30, 2015 | -0.9988M |
| March 31, 2015 | -0.9388M |
| December 31, 2014 | -1.930M |
| September 30, 2014 | -1.979M |
| June 30, 2014 | -4.688M |
| March 31, 2014 | -0.4329M |
| December 31, 2013 | -0.0006M |
| September 30, 2013 | -0.333M |
| June 30, 2013 | -0.5448M |
| March 31, 2013 | -0.3062M |
| December 31, 2012 | -1.498M |
| September 30, 2012 | -0.5593M |
| June 30, 2012 | -0.4073M |
| March 31, 2012 | -1.846M |
| December 31, 2011 | -3.223M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.132M
Minimum
Jun 2023
6.857M
Maximum
Sep 2022
-2.335M
Average
-2.999M
Median
Cash from Operations (Quarterly) Benchmarks
| GlucoTrack Inc | -2.942M |
| AIM ImmunoTech Inc | -4.815M |
| Perspective Therapeutics Inc | 13.85M |
| Protalix BioTherapeutics Inc | 4.188M |
| Armata Pharmaceuticals Inc | -10.58M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -7.392M |
| Free Cash Flow Per Share (Quarterly) | -0.2307 |
| Free Cash Flow Yield | -9.32% |